This week in Other Barks & Bites: the Trump Administration sues Gilead for infringement over HIVE PrEP treatment patents; Senators Inhofe and Wicker ask President Trump to show no leniency on Chinese IP theft; the Supreme Court hears the Allen v. Cooper copyright appeal; the Federal Circuit issues precedential opinions on PTAB evidence admissibility and limitation in patent claim preamble; the Copyright Office says that its digital recordation pilot project is on track for Spring 2020; the PTAB Precedential Opinion Panel (POP) will review the Board’s rejection of substitute patent claims in a motion to amend; “This Is Spinal Tap” creators settle copyright suit; and T-Mobile announces December launch for nationwide 5G network.
- Tech Companies Should Strongly Consider Monetizing Their Patent Portfolios During the Economic Downturn
- (Not) Copyright Infringement: Is dbrand Infringing Nintendo’s IP?
- The Transmissibility of Information: How Your Trade Secrets Are Like a Virus
- Examining Antitrust Guidance on Cooperation in Fighting COVID-19
- Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them
- ‘Unalienable Rights’: Understanding America’s Growing Disdain for Physical and Intangible Property
- This Week in Washington IP: Algorithmic Biases in AI, Federal Funding of R&D Programs and Digitalization-Driven Improvements to Energy Efficiency
- Supreme Court’s Booking.com Ruling Signals Uptick in Registration of ‘Generic.com’ Marks
- Sixth Annual Firecracker 25: My Best Songs of All Time
- Other Barks & Bites for Friday, July 3: Busy Week for USPTO Announcements, New Vision Gaming Says PTAB Institution Process is Unconstitutional, Federal Circuit Affirms Invalidity of Enbrel Patent Claims